Thomas Menter
ORCID: 0000-0002-0847-6156Also affiliated with University Hospital of Basel
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)”.
Martin Fehr, Sämi Schär, Martin Dreyling, Christian Schmidt, Enrico Derenzini +19 more
Ivan T. Lee, Sizun Jiang, Matthias S. Matter, Carol H. Yan, Jonathan B. Overdevest +38 more
Esha Madan, Jochen Wilhelm, Kirsty R. Short, Antonio Palma, Linbu Liao +38 more
Yijia Li, Angela Shih, Sergio Poli, Keiko Kunitoki, George A. Alba +94 more